Circulating CD34+ cells as prognostic and follow-up marker in patients with myelofibrosis undergoing allo-SCT-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Circulating CD34+ cells as prognostic and follow-up marker in patients with myelofibrosis undergoing allo-SCT

Published:2011-02-28 Issue:1 Volume:47 Page:143-145
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Alchalby H,Lioznov M,Fritzsche-Friedland U,Badbaran A,Zabelina T,Bacher U,Stübig T,Ayuk F A,Zander A R,Kröger N

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt201117.pdf

Reference8 articles.

1. Tefferi A, Thiele J, Vardiman JW . The 2008 World Health Organization classification system for myeloproliferative neoplasms: order out of chaos. Cancer 2009; 115: 3842–3847.

2. Andreasson B, Swolin B, Kutti J . Patients with idiopathic myelofibrosis show increased CD34+ cell concentrations in peripheral blood compared to patients with polycythaemia vera and essential thrombocythaemia. Eur J Haematol 2002; 68: 189–193.

3. Douer D, Fabian I, Cline MJ . Circulating pluripotent haemopoietic cells in patients with myeloproliferative disorders. Br J Haematol 1983; 54: 373–381.

4. Hibbin JA, Njoku OS, Matutes E, Lewis SM, Goldman JM . Myeloid progenitor cells in the circulation of patients with myelofibrosis and other myeloproliferative disorders. Br J Haematol 1984; 57: 495–503.

5. Barosi G, Viarengo G, Pecci A, Rosti V, Piaggio G, Marchetti M et al. Diagnostic and clinical relevance of the number of circulating CD34(+) cells in myelofibrosis with myeloid metaplasia. Blood 2001; 98: 3249–3255.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating CD133+/–CD34– Have Increased c-MYC Expression in Myeloproliferative Neoplasms;Turkish Journal of Hematology;2023-03-03

2. The level of peripheral blood circulating CD34+ cells is higher in acute promyelocytic leukemia patients with adverse prognostic factors;Hematology;2016-03-31

3. Clinical Predictors of Outcome in MPN;Hematology/Oncology Clinics of North America;2012-10

4. Allogeneic hematopoietic cell transplantation for myelofibrosis in the era of JAK inhibitors;Blood;2012-08-16

5. Allogeneic stem cell transplant for myelofibrosis patients over age 60: likely impact of the JAK2 inhibitors;Leukemia Supplements;2012-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3